Which has stronger earnings & valuation, HIPO or SPNT?

SiriusPoint has higher revenue and earnings than Hippo. SiriusPoint is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hippo $468.60M 0.07 $57.70M $4.32 7.38 SiriusPoint $3.21B 0.87 $459.60M $4.02 5.89

Is HIPO or SPNT more profitable?

Hippo has a net margin of 23.45% compared to SiriusPoint's net margin of 15.56%. SiriusPoint's return on equity of 16.43% beat Hippo's return on equity. Company Net Margins Return on Equity Return on Assets Hippo 23.45% 12.17% 2.64% SiriusPoint 15.56% 16.43% 2.88%

Does the media prefer HIPO or SPNT?

In the previous week, SiriusPoint had 3 more articles in the media than Hippo. MarketBeat recorded 15 mentions for SiriusPoint and 12 mentions for Hippo. Hippo's average media sentiment score of 0.72 beat SiriusPoint's score of 0.63 indicating that Hippo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hippo 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SiriusPoint 5 Very Positive mention(s) 0 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CLOV or HIPO?

In the previous week, Hippo had 9 more articles in the media than Clover Health Investments. MarketBeat recorded 12 mentions for Hippo and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.77 beat Hippo's score of 0.72 indicating that Clover Health Investments is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clover Health Investments 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hippo 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to HIPO or SKWD?

In the previous week, Hippo had 4 more articles in the media than Skyward Specialty Insurance Group. MarketBeat recorded 12 mentions for Hippo and 8 mentions for Skyward Specialty Insurance Group. Skyward Specialty Insurance Group's average media sentiment score of 0.88 beat Hippo's score of 0.72 indicating that Skyward Specialty Insurance Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hippo 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Skyward Specialty Insurance Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, HIPO or SLDE?

Slide Insurance has higher revenue and earnings than Hippo. Slide Insurance is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hippo $468.60M 0.07 $57.70M $4.32 7.38 Slide Insurance $1.16B 2.00 $443.96M $3.60 5.62

Is HIPO or SLDE more profitable?

Slide Insurance has a net margin of 40.02% compared to Hippo's net margin of 23.45%. Slide Insurance's return on equity of 52.25% beat Hippo's return on equity. Company Net Margins Return on Equity Return on Assets Hippo 23.45% 12.17% 2.64% Slide Insurance 40.02% 52.25% 19.64%

Does the media favor HIPO or SLDE?

In the previous week, Slide Insurance had 9 more articles in the media than Hippo. MarketBeat recorded 21 mentions for Slide Insurance and 12 mentions for Hippo. Hippo's average media sentiment score of 0.72 beat Slide Insurance's score of 0.58 indicating that Hippo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hippo 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Slide Insurance 6 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, PLGO or HIPO?

Fidelis Insurance has higher revenue and earnings than Hippo. Fidelis Insurance is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fidelis Insurance $2.13B 1.02 $225.50M $3.74 6.70 Hippo $468.60M 0.07 $57.70M $4.32 7.38

Does the media prefer PLGO or HIPO?

In the previous week, Hippo had 9 more articles in the media than Fidelis Insurance. MarketBeat recorded 12 mentions for Hippo and 3 mentions for Fidelis Insurance. Hippo's average media sentiment score of 0.72 beat Fidelis Insurance's score of 0.26 indicating that Hippo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fidelis Insurance 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Hippo 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Hippo (HIPO) Competitors

$31.88 +2.05 (+6.86%)

Closing price 07/30/2026 03:59 PM Eastern

Extended Trading

$32.06 +0.19 (+0.58%)

As of 07/30/2026 07:34 PM Eastern

Compare

HIPO vs. SPNT, CLOV, SKWD, SLDE, and PLGO

Should you buy Hippo stock or one of its competitors? MarketBeat compares Hippo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hippo include SiriusPoint (SPNT), Clover Health Investments (CLOV), Skyward Specialty Insurance Group (SKWD), Slide Insurance (SLDE), and Fidelis Insurance (PLGO). These companies are all part of the "insurance" industry.

How does Hippo compare to SiriusPoint?

Hippo (NYSE:HIPO) and SiriusPoint (NYSE:SPNT) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

Hippo has a net margin of 23.45% compared to SiriusPoint's net margin of 15.56%. SiriusPoint's return on equity of 16.43% beat Hippo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hippo	23.45%	12.17%	2.64%
SiriusPoint	15.56%	16.43%	2.88%

SiriusPoint has higher revenue and earnings than Hippo. SiriusPoint is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hippo	$468.60M	0.07	$57.70M	$4.32	7.38
SiriusPoint	$3.21B	0.87	$459.60M	$4.02	5.89

Hippo has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, SiriusPoint has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market.

43.0% of Hippo shares are held by institutional investors. Comparatively, 52.8% of SiriusPoint shares are held by institutional investors. 4.5% of Hippo shares are held by company insiders. Comparatively, 12.2% of SiriusPoint shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hippo currently has a consensus target price of $38.67, suggesting a potential upside of 21.31%. SiriusPoint has a consensus target price of $31.00, suggesting a potential upside of 31.00%. Given SiriusPoint's higher possible upside, analysts plainly believe SiriusPoint is more favorable than Hippo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
SiriusPoint	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, SiriusPoint had 3 more articles in the media than Hippo. MarketBeat recorded 15 mentions for SiriusPoint and 12 mentions for Hippo. Hippo's average media sentiment score of 0.72 beat SiriusPoint's score of 0.63 indicating that Hippo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hippo	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
SiriusPoint	5 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

SiriusPoint beats Hippo on 9 of the 17 factors compared between the two stocks.

How does Hippo compare to Clover Health Investments?

Clover Health Investments (NASDAQ:CLOV) and Hippo (NYSE:HIPO) are both insurance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Clover Health Investments has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market. Comparatively, Hippo has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market.

Clover Health Investments presently has a consensus target price of $4.25, indicating a potential downside of 2.07%. Hippo has a consensus target price of $38.67, indicating a potential upside of 21.31%. Given Hippo's stronger consensus rating and higher probable upside, analysts plainly believe Hippo is more favorable than Clover Health Investments.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clover Health Investments	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 43.0% of Hippo shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Comparatively, 4.5% of Hippo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Hippo had 9 more articles in the media than Clover Health Investments. MarketBeat recorded 12 mentions for Hippo and 3 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.77 beat Hippo's score of 0.72 indicating that Clover Health Investments is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Clover Health Investments	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hippo	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hippo has a net margin of 23.45% compared to Clover Health Investments' net margin of -2.58%. Hippo's return on equity of 12.17% beat Clover Health Investments' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Clover Health Investments	-2.58%	-16.52%	-9.28%
Hippo	23.45%	12.17%	2.64%

Hippo has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clover Health Investments	$2.21B	1.03	-$85.55M	-$0.12	N/A
Hippo	$468.60M	0.07	$57.70M	$4.32	7.38

Summary

Hippo beats Clover Health Investments on 12 of the 17 factors compared between the two stocks.

How does Hippo compare to Skyward Specialty Insurance Group?

Hippo (NYSE:HIPO) and Skyward Specialty Insurance Group (NASDAQ:SKWD) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

43.0% of Hippo shares are held by institutional investors. Comparatively, 94.8% of Skyward Specialty Insurance Group shares are held by institutional investors. 4.5% of Hippo shares are held by company insiders. Comparatively, 8.5% of Skyward Specialty Insurance Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Skyward Specialty Insurance Group has higher revenue and earnings than Hippo. Hippo is trading at a lower price-to-earnings ratio than Skyward Specialty Insurance Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hippo	$468.60M	0.07	$57.70M	$4.32	7.38
Skyward Specialty Insurance Group	$1.42B	1.71	$170.03M	$4.15	14.43

In the previous week, Hippo had 4 more articles in the media than Skyward Specialty Insurance Group. MarketBeat recorded 12 mentions for Hippo and 8 mentions for Skyward Specialty Insurance Group. Skyward Specialty Insurance Group's average media sentiment score of 0.88 beat Hippo's score of 0.72 indicating that Skyward Specialty Insurance Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hippo	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Skyward Specialty Insurance Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hippo has a net margin of 23.45% compared to Skyward Specialty Insurance Group's net margin of 11.36%. Skyward Specialty Insurance Group's return on equity of 18.24% beat Hippo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hippo	23.45%	12.17%	2.64%
Skyward Specialty Insurance Group	11.36%	18.24%	3.69%

Hippo currently has a consensus price target of $38.67, suggesting a potential upside of 21.31%. Skyward Specialty Insurance Group has a consensus price target of $67.67, suggesting a potential upside of 13.02%. Given Hippo's higher probable upside, research analysts plainly believe Hippo is more favorable than Skyward Specialty Insurance Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
Skyward Specialty Insurance Group	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.91

Hippo has a beta of 1.49, suggesting that its share price is 49% more volatile than the broader market. Comparatively, Skyward Specialty Insurance Group has a beta of 0.34, suggesting that its share price is 66% less volatile than the broader market.

Summary

Skyward Specialty Insurance Group beats Hippo on 11 of the 16 factors compared between the two stocks.

How does Hippo compare to Slide Insurance?

Hippo (NYSE:HIPO) and Slide Insurance (NASDAQ:SLDE) are both insurance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

In the previous week, Slide Insurance had 9 more articles in the media than Hippo. MarketBeat recorded 21 mentions for Slide Insurance and 12 mentions for Hippo. Hippo's average media sentiment score of 0.72 beat Slide Insurance's score of 0.58 indicating that Hippo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hippo	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Slide Insurance	6 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Slide Insurance has higher revenue and earnings than Hippo. Slide Insurance is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hippo	$468.60M	0.07	$57.70M	$4.32	7.38
Slide Insurance	$1.16B	2.00	$443.96M	$3.60	5.62

Slide Insurance has a net margin of 40.02% compared to Hippo's net margin of 23.45%. Slide Insurance's return on equity of 52.25% beat Hippo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hippo	23.45%	12.17%	2.64%
Slide Insurance	40.02%	52.25%	19.64%

Hippo presently has a consensus price target of $38.67, indicating a potential upside of 21.31%. Slide Insurance has a consensus price target of $24.60, indicating a potential upside of 21.60%. Given Slide Insurance's stronger consensus rating and higher probable upside, analysts clearly believe Slide Insurance is more favorable than Hippo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71
Slide Insurance	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.78

43.0% of Hippo shares are owned by institutional investors. 4.5% of Hippo shares are owned by company insiders. Comparatively, 50.8% of Slide Insurance shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Slide Insurance beats Hippo on 11 of the 15 factors compared between the two stocks.

How does Hippo compare to Fidelis Insurance?

Fidelis Insurance (NYSE:PLGO) and Hippo (NYSE:HIPO) are both insurance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation, media sentiment and analyst recommendations.

In the previous week, Hippo had 9 more articles in the media than Fidelis Insurance. MarketBeat recorded 12 mentions for Hippo and 3 mentions for Fidelis Insurance. Hippo's average media sentiment score of 0.72 beat Fidelis Insurance's score of 0.26 indicating that Hippo is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fidelis Insurance	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hippo	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

82.0% of Fidelis Insurance shares are owned by institutional investors. Comparatively, 43.0% of Hippo shares are owned by institutional investors. 4.5% of Hippo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Hippo has a net margin of 23.45% compared to Fidelis Insurance's net margin of 15.33%. Fidelis Insurance's return on equity of 14.44% beat Hippo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fidelis Insurance	15.33%	14.44%	2.63%
Hippo	23.45%	12.17%	2.64%

Fidelis Insurance currently has a consensus target price of $27.20, indicating a potential upside of 8.47%. Hippo has a consensus target price of $38.67, indicating a potential upside of 21.31%. Given Hippo's stronger consensus rating and higher probable upside, analysts plainly believe Hippo is more favorable than Fidelis Insurance.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fidelis Insurance	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Hippo	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.71

Fidelis Insurance has a beta of 0.29, suggesting that its stock price is 71% less volatile than the broader market. Comparatively, Hippo has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market.

Fidelis Insurance has higher revenue and earnings than Hippo. Fidelis Insurance is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fidelis Insurance	$2.13B	1.02	$225.50M	$3.74	6.70
Hippo	$468.60M	0.07	$57.70M	$4.32	7.38

Summary

Hippo beats Fidelis Insurance on 11 of the 17 factors compared between the two stocks.

Get Hippo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIPO vs. The Competition

Export

Metric	Hippo	INS Industry	Finance Sector	NYSE Exchange
Market Cap	$31.07M	$22.52B	$14.48B	$23.53B
Dividend Yield	N/A	3.18%	5.68%	4.19%
P/E Ratio	7.38	11.69	20.10	30.73
Price / Sales	0.07	1.75	43.87	19.63
Price / Cash	86.14	13.71	19.26	31.18
Price / Book	1.88	2.72	2.26	4.66
Net Income	$57.70M	$1.89B	$1.14B	$1.07B
7 Day Performance	14.80%	1.13%	0.33%	0.55%
1 Month Performance	13.13%	3.32%	0.79%	1.58%
1 Year Performance	23.40%	7.59%	14.99%	17.66%

Hippo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIPO Hippo	4.0064 of 5 stars	$31.88 +6.9%	$38.67 +21.3%	+26.3%	$31.07M	$468.60M	7.38	620	Trending News Earnings Report Gap Up High Trading Volume
SPNT SiriusPoint	3.6402 of 5 stars	$24.40 -1.1%	$31.00 +27.1%	+20.9%	$2.87B	$3.21B	6.07	1,099	Trending News Earnings Report Upcoming Earnings
CLOV Clover Health Investments	0.7846 of 5 stars	$4.79 +6.3%	$4.25 -11.2%	+49.7%	$2.53B	$1.92B	N/A	680	Upcoming Earnings
SKWD Skyward Specialty Insurance Group	4.0168 of 5 stars	$60.16 -0.9%	$67.67 +12.5%	+21.1%	$2.44B	$1.42B	14.50	400	Positive News Upcoming Earnings
SLDE Slide Insurance	3.1966 of 5 stars	$20.59 -2.1%	$23.75 +15.4%	+4.9%	$2.35B	$1.16B	5.71	392	Trending News Earnings Report Dividend Announcement Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIPO) was last updated on 7/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hippo (HIPO) Competitors

HIPO vs. SPNT, CLOV, SKWD, SLDE, and PLGO

How does Hippo compare to SiriusPoint?

Summary

How does Hippo compare to Clover Health Investments?

Summary

How does Hippo compare to Skyward Specialty Insurance Group?

Summary

How does Hippo compare to Slide Insurance?

Summary

How does Hippo compare to Fidelis Insurance?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIPO vs. The Competition

Hippo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hippo (HIPO) Competitors

HIPO vs. SPNT, CLOV, SKWD, SLDE, and PLGO

How does Hippo compare to SiriusPoint?

Is HIPO or SPNT more profitable?

Which has stronger earnings & valuation, HIPO or SPNT?

Which has more volatility and risk, HIPO or SPNT?

Do insiders & institutionals hold more shares of HIPO or SPNT?

Do analysts rate HIPO or SPNT?

Does the media prefer HIPO or SPNT?

Summary

How does Hippo compare to Clover Health Investments?

Which has more risk & volatility, CLOV or HIPO?

Do analysts rate CLOV or HIPO?

Do institutionals and insiders have more ownership in CLOV or HIPO?

Does the media favor CLOV or HIPO?

Is CLOV or HIPO more profitable?

Which has stronger earnings and valuation, CLOV or HIPO?

Summary

How does Hippo compare to Skyward Specialty Insurance Group?

Do institutionals & insiders hold more shares of HIPO or SKWD?

Which has higher earnings & valuation, HIPO or SKWD?

Does the media refer more to HIPO or SKWD?

Is HIPO or SKWD more profitable?

Do analysts prefer HIPO or SKWD?

Which has more risk & volatility, HIPO or SKWD?

Summary

How does Hippo compare to Slide Insurance?

Does the media favor HIPO or SLDE?

Which has stronger earnings & valuation, HIPO or SLDE?

Is HIPO or SLDE more profitable?

Do analysts prefer HIPO or SLDE?

Do insiders and institutionals have more ownership in HIPO or SLDE?

Summary

How does Hippo compare to Fidelis Insurance?

Does the media prefer PLGO or HIPO?

Do insiders & institutionals believe in PLGO or HIPO?

Is PLGO or HIPO more profitable?

Do analysts recommend PLGO or HIPO?

Which has more risk and volatility, PLGO or HIPO?

Which has higher earnings and valuation, PLGO or HIPO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIPO vs. The Competition

Hippo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools